Arizona Pharmacy CE Requirement 27-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
-
The Pharmacist's Role in the Opioid Crisis, 2nd Edition 6
Course Release: 1/9/2024
About the course
This course will provide pharmacists practicing in healthcare systems and community pharmacy settings an overview of contemporary considerations for ways that the opioid crisis intersects with pharmacy practice. This course will provide pharmacists with a history of the current state of the opioid crisis and how pharmacy practice has expanded to meet patient and community needs as well as ethical dimensions of the opioid crisis and the role of social determinants of health in opioid-related disparities. This course will provide pharmacists with an understanding of the disease state of opioid use disorder and how opioids affect the brain, how the pharmacist can be supportive of patients with opioid use disorder to reduce stigma and facilitate treatment-seeking, and the benefits of medications for opioid use disorder; participants will review the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022 Clinical Practice Guideline).
- Pharmacotherapy to Assist with Smoking Cessation 3
-
Patient Safety and Medication Errors for Pharmacy Professionals 2
Course Release: 4/1/2024
About the course
This educational program is designed to accomplish at least two important goals: first to provide examples of critical potential medication errors, and secondly to offer mechanisms that pharmacy professionals can take to intervene in these mishaps and enhance patient care. In addition to offering these critical examples and potential solutions, two case studies are included to help put some of the ideas into realistic scenarios similar to those that may be encountered in contemporary pharmacy practice. Evidence-based practice information from current peer-reviewed literature is also included for context and ideas for pharmacists to consider in efforts to improve their practice appear throughout the program. Lastly, a post-test is included at the end of the program to test your understanding of the material.
-
A Review of Measles, Mumps, and Rubella for Pharmacists and Pharmacy Technicians, 2nd Edition 2
Course Release: 4/8/2024
About the course
The burden of contagious diseases has been significantly reduced through the use of successful vaccination programs in the United States. Despite this achievement, recent years have seen significant increases in the number of measles cases in the United States, increasing concerns that inadequate vaccination has created a resurgence of a disease that was once considered eliminated.
The contagious viral illnesses of measles, mumps, and rubella can be prevented through the appropriate use of vaccinations. This course serves as a review of the epidemiology, symptoms, treatment, and prevention of these three illnesses.
-
Antibiotic Stewardship, 2nd Edition 2
Course release date: 4/23/2025
Course Overview
The introduction of antibiotics into the practice of medicine has transformed the lives of millions of people. Infections that were once lethal are now easily treatable, and medical advances have been able to move forward through the use of antibiotics. Unfortunately, approximately 30% of all antibiotics administered in hospitals in the United States have been deemed either unnecessary or inappropriate (Centers for Disease Control and Prevention [CDC], 2024a). The misuse of antibiotics has contributed to increases in the rates of Clostridium difficile infections and adverse reactions to antibiotics, as well as the development of resistant strains of bacteria. The CDC estimates that approximately 35,000 deaths annually are caused by antibiotic-resistant organisms (CDC, 2024b).
Inappropriate prescribing of antibiotics is considered a significant public health and patient safety issue. An increasing amount of evidence supports the use of antibiotic stewardship programs to enhance the treatment of infections and decrease adverse events associated with the use of antibiotics. Antibiotic stewardship programs can help prescribers improve patient safety and the quality of patient care by improving infection cure rates, decreasing the rate of treatment failures, increasing the rate of correct antibiotic prescribing, reducing hospital rates of antibiotic resistance and C. difficile infections, as well as increasing cost savings (CDC, 2024a, 2024b).
-
Genital Mycoplasma Infections: Unrecognized STIs 4
Course release date: 3/28/2025
Course Overview
Genital mycoplasma infections are a significant source of morbidity for sexual partners. Genital mycoplasma species include: Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, and Mycoplasma genitalium. These organisms can cause pelvic inflammatory infections, recurrent bacterial vaginitis, and recurrent urinary tract infections. Some have been linked to pregnancy complications, neonatal infections, and infertility. In men, they most often present as nongonococcal urethritis and can lead to orchitis. One species, M. genitalium, was labeled a sexually transmitted infection (STI) in 2015 by the CDC. Despite these risks and the STI label, many providers have never heard of genital mycoplasmas and, if they have, discount their morbidity. When recognized (mostly in men) rarely is their partner treated, leading to both being re-infected. Recognizing and treating these infections would relieve a significant amount of human suffering. This presentation will cover how to recognize, identify, diagnose, and treat mycoplasma infections. -
Telepharmacy: Serving Underserved Populations in a Community Setting, 2nd Edition 3
Course release date: 4/7/2025
Course Overview
This introductory level activity is intended to educate pharmacists and pharmacy technicians on the current landscape of telepharmacy practice and regulations, telepharmacy technology and workflow, remote oversight of advanced pharmacy technicians, and patient care through telepharmacy. -
Antihypertensive Medications: Pharmacology and Healthcare Considerations 3
Course Release Date: 1/6/2025
Course Overview
This course provides a comprehensive overview of antihypertensive medications, focusing on their pharmacology and healthcare considerations. Designed for healthcare professionals, it covers the latest guidelines and classifications for hypertension management, including the 2017 ACC/AHA stages of hypertension. Participants will gain detailed insights into first-line treatments such as calcium channel blockers, ACE inhibitors, ARBs, and diuretics, as well as additional options like sympatholytic drugs, direct vasodilators, and selective aldosterone-receptor antagonists. The course explores each drug class’s mechanism of action, pharmacokinetics, and pharmacodynamics while emphasizing practical aspects such as adverse effects, drug interactions, and patient management strategies. By the end of this course, learners will be equipped with the knowledge to manage hypertension and address associated complications effectively.
-
Rhinitis: Updated Treatment Strategies for Healthcare Providers 2
Course release date: 10/6/2025
Course Overview
The purpose of this course is to explain the epidemiology of rhinitis, discuss the pathophysiology of allergic and nonallergic rhinitis, review assessment and diagnostic testing for rhinitis, and describe the pharmacological and nonpharmacological treatment strategies of allergic and nonallergic rhinitis.